Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Assessing Equity in the Treatment of Acute Angle-Closure Glaucoma in Texas
Author Affiliations & Notes
  • Stephen Laswell
    Medicine, Texas Tech University Health Sciences Center El Paso Paul L Foster School of Medicine, El Paso, Texas, United States
  • Vishwajeet Singh
    Biostatistics and Epidemiology Consulting Lab, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, United States
  • Fatma Dihowm
    Rheumatology, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States
  • Footnotes
    Commercial Relationships   Stephen Laswell None; Vishwajeet Singh None; Fatma Dihowm None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6405. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stephen Laswell, Vishwajeet Singh, Fatma Dihowm; Assessing Equity in the Treatment of Acute Angle-Closure Glaucoma in Texas. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6405.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Acute angle-closure glaucoma (AACG) is an ophthalmic emergency caused by buildup of intraocular pressure. AACG requires prompt treatment to prevent permanent optic nerve damage. We retrospectively analyzed the incidence of AACG in Texas to determine whether cost and treatment choice varied across, race, ethnicity, or region.

Methods : Anonymous records from the Texas outpatient public use data file (PUDF) were searched for all incidence of AACG between January 1, 2016 and December 31, 2018. Data collected included age, race, ethnicity, sex, medical insurance status, procedures implemented, treatment cost, region, and source of admission. Data were analyzed to determine whether either a) cost of treatment, or b) rate of surgical intervention for AACG (including iridotomy, iridectomy, trabeculoplasty, shunt placement, corneal incision) varied demographically or by region.

Results : 1,349 cases of AACG were documented in Texas between 2016 and 2018. Hispanic patients received proportionally fewer surgical interventions for AACG than non-Hispanic patients (P<0.001). Surgical interventions also varied among races, with Asian/Pacific Islanders receiving proportionally more surgical treatment and African Americans receiving less treatment (P<0.001). Patients with private/self-pay health insurance received proportionally more surgical interventions for AACG as compared to patients with other forms of coverage. (P<0.001).

Hispanic patients were charged significantly more ($709.50) than non-Hispanics for their AACG treatment (P<0.01), and were simultaneously less likely than non-Hispanics to receive a surgical intervention for AACG (P<0.001). Costs also differed significantly by race, with Asian/Pacific islanders paying higher costs than other groups (P<0.001).

Conclusions : Treatment costs and surgical interventions vary significantly by race, ethnicity, and insurance status. Some findings, such as higher disease burden among Asian Americans, may be adequately explained by known difference in disease demographic by race. However, instance of lower rates of surgical intervention in combination with higher average cost among Hispanic Americans further investigation, and may represent instances of inequity in the delivery of healthcare in Texas.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×